贝伐单抗对卵巢癌细胞减灭术后八个月阴道残端脏器脱出的影响：一例报告
Influence of bevacizumab on vaginal cuff evisceration eight months after ovarian cancer cytoreduction surgery: A case report.
作者信息
Skwara Amanda J, Schilder Russell J, Zibelli Allison, Rosenblum Norman G
机构信息
Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA.
Department of Medical Oncology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA ; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA.
出版信息
Gynecol Oncol Case Rep. 2013 Jul 1;6:7-9. doi: 10.1016/j.gynor.2013.06.005. eCollection 2013.
Abstract
•44 year old woman treated with bevacizumab for metastatic epithelial ovarian cancer•The patient experienced vaginal cuff dehiscence and evisceration at 8 months post-operatively.•Metastasis at the surgical site and chronic inflammation implicated.
摘要
•44岁女性，接受贝伐单抗治疗转移性上皮性卵巢癌
•患者术后8个月出现阴道残端裂开和脏器脱出。
•考虑手术部位转移和慢性炎症。
相似文献
1
Influence of bevacizumab on vaginal cuff evisceration eight months after ovarian cancer cytoreduction surgery: A case report.贝伐单抗对卵巢癌细胞减灭术后八个月阴道残端脏器脱出的影响：一例报告
Gynecol Oncol Case Rep. 2013 Jul 1;6:7-9. doi: 10.1016/j.gynor.2013.06.005. eCollection 2013.
2
Delayed postcoital vaginal cuff dehiscence with small bowel evisceration after robotic-assisted staging surgery.机器人辅助分期手术后出现延迟性性交后阴道残端裂开并伴有小肠脱出。
Taiwan J Obstet Gynecol. 2017 Apr;56(2):258-260. doi: 10.1016/j.tjog.2016.02.022.
3
Case of vaginal cuff dehiscence and small bowel evisceration after laparoscopic radical cystectomy.腹腔镜根治性膀胱切除术后阴道残端裂开并小肠脱出病例
IJU Case Rep. 2021 Jul 13;4(6):351-354. doi: 10.1002/iju5.12346. eCollection 2021 Nov.
4
Laparoscopic Repair of Vaginal Evisceration after Abdominal Hysterectomy for Uterine Corpus Cancer: A Case Report and Literature Review.子宫体癌腹式子宫切除术后阴道脏器膨出的腹腔镜修复：一例报告及文献综述
J Nippon Med Sch. 2017;84(2):90-95. doi: 10.1272/jnms.84.90.
5
Post-coital vaginal cuff dehiscence with small bowel evisceration after laparoscopic type II radical hysterectomy: A case report.腹腔镜下II型根治性子宫切除术后性交后阴道残端裂开伴小肠脱出：一例报告
Int J Surg Case Rep. 2016;26:81-3. doi: 10.1016/j.ijscr.2016.07.024. Epub 2016 Jul 25.
6
Two cases of post-coital vaginal cuff dehiscence with small bowel evisceration after robotic-assisted laparoscopic hysterectomy.两例机器人辅助腹腔镜子宫切除术后性交后阴道残端裂开伴小肠脱出病例
Int J Surg Case Rep. 2013;4(7):603-5. doi: 10.1016/j.ijscr.2013.04.001. Epub 2013 Apr 10.
7
Transvaginal Management of Vaginal Cuff Dehiscence with Bowel Evisceration following Delayed Diagnosis.延迟诊断后经阴道处理伴肠脱垂的阴道残端裂开
Case Rep Obstet Gynecol. 2017;2017:4985382. doi: 10.1155/2017/4985382. Epub 2017 Dec 21.
8
Totally laparoscopic treatment of vaginal cuff dehiscence: A case report and systematic literature review.
Int J Surg Case Rep. 2016;25:79-82. doi: 10.1016/j.ijscr.2016.06.004. Epub 2016 Jun 16.
9
Vaginal cuff dehiscence resulting in small-bowel evisceration. A case report.
Acta Biomed. 2016 Sep 13;87(2):212-4.
10
Treatment of vaginal cuff evisceration.阴道残端膨出的治疗。
Obstet Gynecol. 2014 Oct;124(4):705-708. doi: 10.1097/AOG.0000000000000463.
本文引用的文献
1
Evaluation of intraoperative and postoperative complications related to lymphadenectomy in ovarian cancer patients.评估卵巢癌患者淋巴结清扫术相关的术中及术后并发症。
Oncol Lett. 2011 May;2(3):537-541. doi: 10.3892/ol.2011.281. Epub 2011 Mar 21.
2
Bevacizumab: overview of the literature.贝伐珠单抗：文献综述。
Expert Rev Anticancer Ther. 2012 May;12(5):567-80. doi: 10.1586/era.12.13.
3
CCR2 recruits an inflammatory macrophage subpopulation critical for angiogenesis in tissue repair.CCR2 招募了一个炎症性巨噬细胞亚群，该亚群对于组织修复中的血管生成至关重要。
Blood. 2012 Jul 19;120(3):613-25. doi: 10.1182/blood-2012-01-403386. Epub 2012 May 10.
4
Incorporation of bevacizumab in the primary treatment of ovarian cancer.贝伐珠单抗在卵巢癌初始治疗中的应用。
N Engl J Med. 2011 Dec 29;365(26):2473-83. doi: 10.1056/NEJMoa1104390.
5
Vaginal cuff dehiscence: risk factors and management.阴道残端裂开：危险因素和处理。
Am J Obstet Gynecol. 2012 Apr;206(4):284-8. doi: 10.1016/j.ajog.2011.08.026. Epub 2011 Aug 27.
6
Late anastomotic colonic dehiscence due to antiangiogenic treatment, a specific drug-class complication requiring specific treatment: an example of pazopanib complication.晚期吻合口结肠裂开与抗血管生成治疗相关，一种特定药物类别并发症，需要特定治疗：帕唑帕尼并发症的一个例子。
Clin Res Hepatol Gastroenterol. 2011 Feb;35(2):135-9. doi: 10.1016/j.clinre.2010.10.003.
7
Wound complications after bevacizumab treatment in patients operated on for ovarian cancer.卵巢癌手术后贝伐珠单抗治疗后的伤口并发症。
Anticancer Res. 2010 Nov;30(11):4743-7.
8
Antiangiogenic agents and late anastomotic complications.抗血管生成药物与晚期吻合口并发症。
J Surg Oncol. 2010 Feb 1;101(2):180-3. doi: 10.1002/jso.21447.
9
Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer.贝伐单抗用于铂耐药卵巢癌或腹膜浆液性癌患者的II期研究。
J Clin Oncol. 2007 Nov 20;25(33):5180-6. doi: 10.1200/JCO.2007.12.0782.
10
Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study.贝伐单抗用于持续性或复发性上皮性卵巢癌或原发性腹膜癌的II期试验：一项妇科肿瘤学组研究
J Clin Oncol. 2007 Nov 20;25(33):5165-71. doi: 10.1200/JCO.2007.11.5345.
Zotero 插件